These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12884733)

  • 21. The role of glutamate in the pathophysiology of Parkinson's disease.
    Blandini F; Greenamyre JT; Nappi G
    Funct Neurol; 1996; 11(1):3-15. PubMed ID: 8936453
    [No Abstract]   [Full Text] [Related]  

  • 22. Functional anatomy of thalamus and basal ganglia.
    Herrero MT; Barcia C; Navarro JM
    Childs Nerv Syst; 2002 Aug; 18(8):386-404. PubMed ID: 12192499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology of Parkinson's disease.
    Bonnet AM; Houeto JL
    Biomed Pharmacother; 1999 Apr; 53(3):117-21. PubMed ID: 10349507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuropathology of the basal ganglia in Parkinson's disease with a special reference to its responsible lesion].
    Tanaka J; Fukuda T
    Nihon Rinsho; 1997 Jan; 55(1):32-8. PubMed ID: 9014420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease.
    Brown P
    Mov Disord; 2003 Apr; 18(4):357-63. PubMed ID: 12671940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the dopaminergic deficits in Parkinson's disease: insights into disease heterogeneity.
    Lewis SJ; Barker RA
    J Clin Neurosci; 2009 May; 16(5):620-5. PubMed ID: 19285870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of parkinsonian motor behaviors by optogenetic control of Basal Ganglia circuitry.
    Mikell CB; McKhann GM
    Neurosurgery; 2010 Oct; 67(4):N28-9. PubMed ID: 20881550
    [No Abstract]   [Full Text] [Related]  

  • 28. 300-Hz subthalamic oscillations in Parkinson's disease.
    Foffani G; Priori A; Egidi M; Rampini P; Tamma F; Caputo E; Moxon KA; Cerutti S; Barbieri S
    Brain; 2003 Oct; 126(Pt 10):2153-63. PubMed ID: 12937087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional neuropathology in Parkinson's disease.
    Gibb WR
    Eur Neurol; 1997; 38 Suppl 2():21-5. PubMed ID: 9387799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiology and pathophysiology of the basal ganglia-thalamo-cortical networks.
    Rosin B; Nevet A; Elias S; Rivlin-Etzion M; Israel Z; Bergman H
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S437-9. PubMed ID: 18267279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurosurgical therapy of Parkinson disease. Deep brain stimulation].
    Vesper J; Funk T; Kern BC; Klostermann F; Straschill M; Brock M
    MMW Fortschr Med; 2001 May; 143 Suppl 2():50-3. PubMed ID: 11434259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep brain stimulation: the case for.
    O'Sullivan DJ
    J Clin Neurosci; 2001 May; 8(3):290-1; discussion 293-4. PubMed ID: 11386813
    [No Abstract]   [Full Text] [Related]  

  • 33. Anatomy and physiology of the basal ganglia: implications for deep brain stimulation for Parkinson's disease.
    Kopell BH; Rezai AR; Chang JW; Vitek JL
    Mov Disord; 2006 Jun; 21 Suppl 14():S238-46. PubMed ID: 16810674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic strategies for neurodegenerative disorders: emerging clues from Parkinson's disease.
    Bjarkam CR; Sørensen JC
    Biol Psychiatry; 2004 Aug; 56(4):213-6. PubMed ID: 15312807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurophysiologic and neuropathological analysis of Parkinson's disease and its treatment with stereotaxic method].
    Starikov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(11):29-33. PubMed ID: 15581034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basal ganglia physiology and deep brain stimulation.
    Lozano AM; Snyder BJ; Hamani C; Hutchison WD; Dostrovsky JO
    Mov Disord; 2010; 25 Suppl 1():S71-5. PubMed ID: 20187251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.
    Bezard E; Brotchie JM; Gross CE
    Nat Rev Neurosci; 2001 Aug; 2(8):577-88. PubMed ID: 11484001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The current model of basal ganglia organization under scrutiny.
    Parent A; Cicchetti F
    Mov Disord; 1998 Mar; 13(2):199-202. PubMed ID: 9539330
    [No Abstract]   [Full Text] [Related]  

  • 39. Commentary to "excessive synchronisation of basal ganglia neurons at 20 Hz slows movement in Parkinson's disease".
    Aziz T
    Exp Neurol; 2007 Jul; 206(1):16. PubMed ID: 17511986
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of severe Parkinson disease with electric stimulation of the subthalamic nuclei].
    Ostergaard K; Sunde NA; Sørensen JC; Dupont E
    Ugeskr Laeger; 2000 Oct; 162(41):5491-6. PubMed ID: 11068525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.